1. Home
  2. ALNY
  3. ALNY News

Latest Alnylam Pharmaceuticals Inc. (ALNY) News on September 9, 2025

ALNY

MT Newswires

18 hours ago

Alnylam Launches $500 Million Convertible Notes Offering

Alnylam Announces Proposed Offering of $500 Million Convertible Senior Notes
ALNY

Business Wire

19 hours ago

Alnylam Announces Proposed Offering of $500 Million Convertible Senior Notes

Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth?
ALNY

Zacks

a day ago

Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth?

Are Options Traders Betting on a Big Move in Alnylam Pharmaceuticals Stock?
ALNY

Zacks

5 days ago

Are Options Traders Betting on a Big Move in Alnylam Pharmaceuticals Stock?

RNAi Technology Market Size to Reach USD 6.63 Billion with 10.4% CAGR by 2033, Report by DataM Intelligence
ALNY

PR Newswire

5 days ago

RNAi Technology Market Size to Reach USD 6.63 Billion with 10.4% CAGR by 2033, Report by DataM Intelligence

ALNY

MT Newswires

7 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,557,649, According to a Recent SEC Filing

Should You Add Alnylam Pharmaceuticals (ALNY) to Your Portfolio?
ALNY

Insider Monkey

7 days ago

Should You Add Alnylam Pharmaceuticals (ALNY) to Your Portfolio?

Hemab Therapeutics Expands Leadership with Appointment of Anant Murthy, PhD, as Chief Operating Officer
ALNY

PR Newswire

7 days ago

Hemab Therapeutics Expands Leadership with Appointment of Anant Murthy, PhD, as Chief Operating Officer

Alnylam reports new analysis from trial of Amvuttra for ATTR-CM
ALNY

Clinical Trials Arena

7 days ago

Alnylam reports new analysis from trial of Amvuttra for ATTR-CM

Startup Corsera Health aims to bring preventive heart medicine to the masses
ALNY

BioPharma Dive

7 days ago

Startup Corsera Health aims to bring preventive heart medicine to the masses

ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win
ALNY

Zacks

8 days ago

ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win

Analysts Are Optimistic We'll See A Profit From Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
ALNY

Simply Wall St.

9 days ago

Analysts Are Optimistic We'll See A Profit From Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Large-cap biotech is a sector to watch for investors: Analysts
ALNY

Yahoo Finance

9 days ago

Large-cap biotech is a sector to watch for investors: Analysts

New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM
ALNY

Business Wire

9 days ago

New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM

Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension
ALNY

Business Wire

10 days ago

Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial
ALNY

Business Wire

10 days ago

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial

Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
ALNY

GlobeNewswire

10 days ago

Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension

Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?
ALNY

Zacks

12 days ago

Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?

Next Generation Drug Conjugates Market Report 2025-2035, with Profiles of Advanced Accelerator Applications, Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Geron, & Ionis Pharmaceuticals
ALNY

GlobeNewswire

12 days ago

Next Generation Drug Conjugates Market Report 2025-2035, with Profiles of Advanced Accelerator Applications, Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Geron, & Ionis Pharmaceuticals

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
ALNY

Zacks

12 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Alnylam to Webcast Presentations at Upcoming September Investor Conferences
ALNY

Business Wire

13 days ago

Alnylam to Webcast Presentations at Upcoming September Investor Conferences

Calculating The Fair Value Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
ALNY

Simply Wall St.

14 days ago

Calculating The Fair Value Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Scenic Enters License and Research Agreement with Alnylam
ALNY

GlobeNewswire

14 days ago

Scenic Enters License and Research Agreement with Alnylam

Leaders Come Together to Advance the Industry at Veeva Summit
ALNY

PR Newswire

19 days ago

Leaders Come Together to Advance the Industry at Veeva Summit

ALNY

MT Newswires

21 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $632,759, According to a Recent SEC Filing

ALNY

MT Newswires

21 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $3,163,346, According to a Recent SEC Filing

ALNY

MT Newswires

21 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,030,727, According to a Recent SEC Filing

ALNY

MT Newswires

21 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,299,746, According to a Recent SEC Filing

Three Companies That Might Be Priced Below Their Estimated Value
ALNY

Simply Wall St.

21 days ago

Three Companies That Might Be Priced Below Their Estimated Value

Is Alnylam Pharmaceuticals (NASDAQ:ALNY) Using Too Much Debt?
ALNY

Simply Wall St.

23 days ago

Is Alnylam Pharmaceuticals (NASDAQ:ALNY) Using Too Much Debt?

Private Credit Is a Booming Business. Where One Pro Sees Risks and Opportunities Now.
ALNY

Barrons.com

25 days ago

Private Credit Is a Booming Business. Where One Pro Sees Risks and Opportunities Now.

Profits May Be Just Around the Corner for This Strong-Buy Pharma Stock
ALNY

Barchart

a month ago

Profits May Be Just Around the Corner for This Strong-Buy Pharma Stock

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
ALNY

Zacks

a month ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock
ALNY

Simply Wall St.

a month ago

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock

Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025
ALNY

Business Wire

a month ago

Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025

Exploring Three High Growth Tech Stocks In The US Market
ALNY

Simply Wall St.

2 months ago

Exploring Three High Growth Tech Stocks In The US Market

Exploring 3 High Growth Tech Stocks in the US Market
ALNY

Simply Wall St.

2 months ago

Exploring 3 High Growth Tech Stocks in the US Market

Exploring High Growth Tech Stocks In The US Market
ALNY

Simply Wall St.

2 months ago

Exploring High Growth Tech Stocks In The US Market

When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Become Profitable?
ALNY

Simply Wall St.

2 months ago

When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Become Profitable?

Exploring Three High Growth Tech Stocks in the US Market
ALNY

Simply Wall St.

2 months ago

Exploring Three High Growth Tech Stocks in the US Market

Exploring US High Growth Tech Stocks For Potential Opportunities
ALNY

Simply Wall St.

2 months ago

Exploring US High Growth Tech Stocks For Potential Opportunities

US High Growth Tech Stocks To Watch In June 2025
ALNY

Simply Wall St.

2 months ago

US High Growth Tech Stocks To Watch In June 2025

High Growth Tech Stocks To Watch In US June 2025
ALNY

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In US June 2025

Exploring US High Growth Tech Stocks To Watch In June 2025
ALNY

Simply Wall St.

3 months ago

Exploring US High Growth Tech Stocks To Watch In June 2025

Exploring 3 High Growth Tech Stocks In The US Market
ALNY

Simply Wall St.

3 months ago

Exploring 3 High Growth Tech Stocks In The US Market

High Growth Tech Stocks in US for June 2025
ALNY

Simply Wall St.

3 months ago

High Growth Tech Stocks in US for June 2025

Exploring 3 High Growth Tech Stocks in the US Market
ALNY

Simply Wall St.

3 months ago

Exploring 3 High Growth Tech Stocks in the US Market

Exploring Three High Growth Tech Stocks In The US Market
ALNY

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks In The US Market

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase
ALNY

Simply Wall St.

3 months ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase

Alnylam names Pushkal Garg as EVP, chief research and development officer
ALNY

TipRanks

3 months ago

Alnylam names Pushkal Garg as EVP, chief research and development officer

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer
ALNY

Business Wire

3 months ago

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer

Exploring High Growth Tech Opportunities in US Markets
ALNY

Simply Wall St.

3 months ago

Exploring High Growth Tech Opportunities in US Markets

Exploring High Growth Tech Stocks In The US This June 2025
ALNY

Simply Wall St.

3 months ago

Exploring High Growth Tech Stocks In The US This June 2025

The European Commission Approves Alnylam’s AMVUTTRA
ALNY

Insider Monkey

3 months ago

The European Commission Approves Alnylam’s AMVUTTRA

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program
ALNY

GlobeNewswire

3 months ago

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program

Alnylam Wins EC Nod for Label Expansion of Amvuttra for ATTR-CM
ALNY

Zacks

3 months ago

Alnylam Wins EC Nod for Label Expansion of Amvuttra for ATTR-CM

EC approves Alnylam’s vutrisiran for ATTR-CM treatment
ALNY

Pharmaceutical Technology

3 months ago

EC approves Alnylam’s vutrisiran for ATTR-CM treatment

ALNY

MT Newswires

3 months ago

Alnylam Gets EU Approval for RNAi Drug to Treat Transthyretin Amyloidosis With Cardiomyopathy

Alnylam Receives European Commission Approval for AMVUTTRA® (vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy
ALNY

Business Wire

3 months ago

Alnylam Receives European Commission Approval for AMVUTTRA® (vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Why Is Sarepta Therapeutics (SRPT) Up 7.7% Since Last Earnings Report?
ALNY

Zacks

3 months ago

Why Is Sarepta Therapeutics (SRPT) Up 7.7% Since Last Earnings Report?

This week in Trumponomics: Too bad TACO isn’t true
ALNY

Yahoo Finance

3 months ago

This week in Trumponomics: Too bad TACO isn’t true

AI ecosystem isn't just Nvidia: Unlock it further with this ETF
ALNY

Yahoo Finance Video

3 months ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Ford recalls more than 29,000 vehicles in the US, NHTSA says
ALNY

Reuters

3 months ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Smoke from Canadian wildfires worsens air quality in Dakotas, Midwestern states
ALNY

USA TODAY

3 months ago

Smoke from Canadian wildfires worsens air quality in Dakotas, Midwestern states

Saturday Sessions: OK Go performs "Love"
ALNY

CBS News Videos

3 months ago

Saturday Sessions: OK Go performs "Love"

Behind the scenes of an OK Go music video
ALNY

CBS News Videos

3 months ago

Behind the scenes of an OK Go music video

Some Investors May Be Worried About Marine Products' (NYSE:MPX) Returns On Capital
ALNY

Simply Wall St.

3 months ago

Some Investors May Be Worried About Marine Products' (NYSE:MPX) Returns On Capital

Dow Jones Futures: Stocks At Key Levels Amid Trump Tariff News; Palantir Breaks Out As Tesla, Nvidia Fall Back
ALNY

Investor's Business Daily

3 months ago

Dow Jones Futures: Stocks At Key Levels Amid Trump Tariff News; Palantir Breaks Out As Tesla, Nvidia Fall Back

Alnylam to Webcast Presentation at Goldman Sachs 46th Annual Global Healthcare Conference
ALNY

Business Wire

3 months ago

Alnylam to Webcast Presentation at Goldman Sachs 46th Annual Global Healthcare Conference

3 High-Flying Stocks That Could Soar Even More
ALNY

Motley Fool

4 months ago

3 High-Flying Stocks That Could Soar Even More

Alnylam Issues 2024 Corporate Responsibility Report
ALNY

Business Wire

4 months ago

Alnylam Issues 2024 Corporate Responsibility Report

ALNY

Morningstar Research

4 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

ALNY

MT Newswires

4 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $3,124,217, According to a Recent SEC Filing

AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B
ALNY

Business Wire

4 months ago

AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B

High Growth US Tech Stocks To Watch In May 2025
ALNY

Simply Wall St.

4 months ago

High Growth US Tech Stocks To Watch In May 2025

Alnylam Pharmaceuticals, Inc. (ALNY): Among the Best Growth Stocks to Buy and Hold for the Long Term
ALNY

Insider Monkey

4 months ago

Alnylam Pharmaceuticals, Inc. (ALNY): Among the Best Growth Stocks to Buy and Hold for the Long Term

Alnylam Pharmaceuticals (NasdaqGS:ALNY) To Present Pivotal TTR Franchise Data At Heart Failure Congress
ALNY

Simply Wall St.

4 months ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) To Present Pivotal TTR Franchise Data At Heart Failure Congress

Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability
ALNY

Simply Wall St.

4 months ago

Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability

ALNY

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Vir Biotechnology Inc Earnings Call

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock
ALNY

Simply Wall St.

4 months ago

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock

Alnylam keeps pushing the rare disease paradigm as RNAi promises even wider indications
ALNY

Pharma Voice

4 months ago

Alnylam keeps pushing the rare disease paradigm as RNAi promises even wider indications

Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...
ALNY

GuruFocus.com

4 months ago

Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...

Alnylam to Webcast Presentation at BofA Securities 2025 Health Care Conference
ALNY

Business Wire

4 months ago

Alnylam to Webcast Presentation at BofA Securities 2025 Health Care Conference

Analyst Estimates: Here's What Brokers Think Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) After Its First-Quarter Report
ALNY

Simply Wall St.

4 months ago

Analyst Estimates: Here's What Brokers Think Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) After Its First-Quarter Report

Alnylam Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations
ALNY

Simply Wall St.

4 months ago

Alnylam Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y
ALNY

Zacks

4 months ago

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y

ALNY

MT Newswires

4 months ago

UBS Adjusts Alnylam Pharmaceuticals Price Target to $349 From $331, Maintains Buy Rating

Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ...
ALNY

GuruFocus.com

4 months ago

Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ...

ALNY

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Alnylam Pharmaceuticals Inc Earnings Call

ALNY

Morningstar Research

4 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics
ALNY

Zacks

4 months ago

Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics

Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
ALNY

Zacks

4 months ago

Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates

ALNY

MT Newswires

4 months ago

Alnylam Q1 Non-GAAP Net Loss Narrows, Revenue Rises

ALNY

Associated Press Finance

4 months ago

Alnylam: Q1 Earnings Snapshot

Alnylam Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Period Progress
ALNY

Business Wire

4 months ago

Alnylam Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Period Progress

ALNY

Morningstar Research

4 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

BridgeBio Breaks Out After Pfizer-Rivaling Heart Drug Obliterates Sales Expectations
ALNY

Investor's Business Daily

4 months ago

BridgeBio Breaks Out After Pfizer-Rivaling Heart Drug Obliterates Sales Expectations

BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations
ALNY

Investor's Business Daily

4 months ago

BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations

Seeking Clues to Alnylam (ALNY) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
ALNY

Zacks

4 months ago

Seeking Clues to Alnylam (ALNY) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Receives CHMP Backing For RNAi Therapy Vutrisiran In Europe
ALNY

Simply Wall St.

4 months ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Receives CHMP Backing For RNAi Therapy Vutrisiran In Europe

Share on Social Networks: